
Camden Partners
Description
Camden Partners is a Baltimore-based private equity firm established in 1995, specializing in providing growth capital to companies across the United States. The firm primarily targets three key sectors: education, healthcare, and technology-enabled business services. Their investment philosophy centers on partnering with experienced management teams to help scale businesses that have demonstrated strong market traction and significant growth potential. They seek to support companies through various stages of expansion, including market penetration, product development, and strategic acquisitions, aiming to foster long-term value creation.
The firm's investment strategy is focused on identifying companies poised for substantial growth within their target industries. Camden Partners typically deploys equity investments ranging from $10 million to $30 million per company, aiming to be a significant minority or control investor. They emphasize a hands-on approach, leveraging their extensive network and operational expertise to assist portfolio companies with strategic planning, talent acquisition, and operational improvements. This collaborative model is designed to accelerate growth and enhance value for their portfolio companies by providing more than just capital.
Since its inception, Camden Partners has built a robust portfolio, having invested in over 80 companies across its core sectors. The firm has successfully raised over $1 billion in capital across multiple funds, demonstrating a strong track record and investor confidence. Their long-term perspective and commitment to fostering sustainable growth have positioned them as a notable player in the growth equity landscape, consistently seeking opportunities to back innovative businesses that address critical market needs within education, healthcare, and business services.
Investor Profile
Camden Partners has backed more than 76 startups, with 0 new investments in the last 12 months alone. The firm has led 46 rounds, about 61% of its total and boasts 30 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Ireland.
- Strong thematic focus on Health Care, Software, Biotechnology.
- Typical check size: $10M – $30M.
Stage Focus
- Private Equity (26%)
- Series Unknown (17%)
- Series B (16%)
- Series A (11%)
- Series C (11%)
- Series D (7%)
- Convertible Note (5%)
- Post Ipo Debt (3%)
- Seed (1%)
- Post Ipo Equity (1%)
Country Focus
- United States (93%)
- United Kingdom (1%)
- Ireland (1%)
- Israel (1%)
Industry Focus
- Health Care
- Software
- Biotechnology
- Medical
- Information Technology
- Enterprise Software
- Saas
- Payments
- Medical Device
- Education
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.